Bacil Pharma Ltd (524516) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524516 | NSE: | Pharmaceuticals & Drugs | Small Cap

Bacil Pharma Share Price

39.52 -1.63 -3.96%
as on 05-Dec'25 12:14

Bacil Pharma Ltd (524516) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524516 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Bacil Pharma

Based on:

M-Cap below 100cr DeciZen not available

Bacil Pharma stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
92.87
Market Cap:
59.1 Cr.
52-wk low:
26.7
52-wk high:
62.6

Is Bacil Pharma Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Bacil Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bacil Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -1.1%-0%-83%-16.2%-17.2%-15.1%-273.3%-8.5%-4.8%3%-
Value Creation
Index
-1.1-1.0-6.9-2.2-2.2-2.1-20.5-1.6-1.3-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000000000
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS -0.1-0.1-2.3-0.4-0.2-0.2-2.1-0.2-0.200.4
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 8.69.82.72.21.31.310.8118.618.6
Adj Net
Profit
-0.1-0.1-1.3-0.2-0.1-0.1-1.2-0.1-0.101
Cash Flow from Ops. 0.1-01.4-0.3-0.4-0.4-4-0.2-00.4-
Debt/CF from Ops. 4.5-66.60-0.3-0.5-0.4-0-0.1-33.90.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPS8.9%71.1%165%1798%
Share Price 23.8% 47.8% 74.8% -28.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-1-1.2-30.8-11.1-8.1-10.1-94-11.8-11.20.22.4
Op. Profit
Mgn %
0000000000NAN
Net Profit
Mgn %
0000000000INF
Debt to
Equity
0.10.100.10.10.1000.100
Working Cap
Days
00000000000
Cash Conv.
Cycle
00000000000

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Bacil Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 0.4 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 18.6 -
Reserves (₹ Cr.) 12 -
P/BV 2.21 -
PE 92.87 -
From the Market
52 Week Low / High (₹) 26.69 / 62.56
All Time Low / High (₹) 0.80 / 62.56
Market Cap (₹ Cr.) 59.1
Equity (₹ Cr.) 14.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Bacil Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Bacil Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Bacil Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0000000000
Operating Expenses 0.130.170.300.430.440.303.910.210.190.25
Manufacturing Costs00.010.030.01000000
Material Costs0000000000
Employee Cost 0.040.080.130.080.090.050.060.090.100.14
Other Costs 0.090.090.140.340.340.253.850.120.090.11
Operating Profit -0.13-0.17-0.30-0.43-0.44-0.30-3.91-0.21-0.19-0.25
Operating Profit Margin (%) ----------
Other Income 0.060.170.270.090.140.070.060.110.130.66
Interest 000.0300.0100000
Depreciation 000.010.010.0100000
Exceptional Items 00-3.690000000
Profit Before Tax -0.07-0-3.75-0.34-0.32-0.24-3.86-0.10-0.060.41
Tax 00-0-0-0-0-0000
Profit After Tax -0.07-0-3.75-0.34-0.32-0.24-3.86-0.10-0.060.40
PAT Margin (%) ----------
Adjusted EPS (₹)-0.10.0-6.4-0.6-0.5-0.4-6.6-0.2-0.10.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 6.406.432.241.911.391.391.221.101.2125.43
Share Capital 6.536.536.536.536.536.536.536.536.5313.97
Reserves -0.13-0.09-4.29-4.62-5.14-5.14-5.30-5.43-5.3111.46
Minority Interest0000000000
Debt0.270.3100.100.170.180.030.020.100.16
Long Term Debt0000000000
Short Term Debt0.270.3100.100.170.180.030.020.100.16
Trade Payables0000.040.040.010.01000
Others Liabilities 0.020.022.412.392.322.40-0.11-0.11-0.04-0.05
Total Liabilities 6.696.774.654.433.913.981.161.011.2725.55

Fixed Assets

Gross Block5.265.952.562.562.562.560.060.060.060.06
Accumulated Depreciation0.010.010.020.030.040.040.050.050.050.06
Net Fixed Assets 5.255.942.532.532.522.510.010.010.010
CWIP 0000000000
Investments 0.510.541.150.960.430.370.310.430.6121.36
Inventories0000000000
Trade Receivables000.010000000.05
Cash Equivalents 0.020.040.270.090.040.100.230.030.042.86
Others Assets 0.910.250.680.860.920.990.610.550.611.29
Total Assets 6.696.774.654.433.913.981.161.011.2725.55

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.06-01.44-0.30-0.38-0.40-4.01-0.15-00.40
PBT -0.07-0-3.75-0.34-0.32-0.24-3.86-0.10-0.060.41
Adjustment 003.43-0.09-0.13-0.14-0.05-0.03-0.03-0.02
Changes in Working Capital 0.13-0.011.760.130.07-0.02-0.1-0.020.080.02
Tax Paid 0000000000
Cash Flow From Investing Activity -0.050.02-1.200.280.390.533.81-0.120.080.34
Capex -5.240-0.30-000.39000.050.31
Net Investments 00.02-0.930.190.2503.75-0.1500
Others 5.1900.030.090.140.140.060.030.030.03
Cash Flow From Financing Activity 000-0.16-0.06-0.070.330.06-0.062.08
Net Proceeds from Shares 0000000002.76
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 000-0.16-0.06-0.070.330.06-0.06-0.68
Net Cash Flow 0.010.020.23-0.18-0.050.060.13-0.200.012.82

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-1.23-0.04-101.39-23.83-31.16-31.82-575.48-19.42-11.383.19
ROCE (%)-1.06-0.03-83.02-16.18-17.2-15.05-273.27-8.45-4.83.03
Asset Turnover Ratio0000000000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/A1
Working Capital Days
Receivable Days0000000000
Inventory Days0000000000
Payable Days0000000000

Bacil Pharma Ltd Stock News

Bacil Pharma Ltd FAQs

The current trading price of Bacil Pharma on 05-Dec-2025 12:14 is ₹39.52.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Bacil Pharma stood at ₹59.06.
The latest P/E ratio of Bacil Pharma as of 04-Dec-2025 is 92.87.
The latest P/B ratio of Bacil Pharma as of 04-Dec-2025 is 2.21.
The 52-week high of Bacil Pharma is ₹62.56 and the 52-week low is ₹26.69.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bacil Pharma is ₹0.00 ( Cr.) .

About Bacil Pharma Ltd

Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Business profile:

The company manufactures bulk pharmaceutical/ chemical manufacturing heavy, medium and fine chemicals. The Lote-Parshuraram plant also has manufacture facility for herbal extract and drug intermediates.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×